See also this year's filing and all EDGAR filings for this company.
PDF Report 0001509190_2018_Aratana_Therapeutics_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001509190, Aratana Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 85,239,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 47,911,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,166,000 |
| 3 | remainder_Assets | 876,000 |
| 4 | LiabilitiesCurrent | 35,496,000 |
| 5 | LiabilitiesNoncurrent | 70,000 |
| 6 | remainder_Liabilities | 19,492,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 29,184,475 |
| 9 | ResearchAndDevelopmentExpense | 13,541,048 |
| 10 | remainder_Expenses | 20,059,260 |
| 11 | remainder_Revenues | 28,917,949 |
| 12 | remainder_NetIncome | -3,002,534 |
| 13 | remainder_ComprehensiveNetIncome | 4,752,064 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 135,192,000 |
| 1 | Liabilities | 55,058,000 |
| 2 | Expenses | 62,784,783 |
| 3 | Revenues | 28,917,949 |
| 4 | StockholdersEquity | 80,134,000 |
| 5 | NetIncome | -36,869,368 |
| 6 | ComprehensiveNetIncome | -34,493,336 |
| 7 | BaseVar | 144,853,665 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.47 |
| 9 | EconomicCapitalRatio | 2.66 |
Edgar->Model Mapping
Feature Distribution
Change over Time
